FDA Radiology AI Devices

The Tomey Cornea/Anterior Segment OCT (CASIA2) is a medical imaging device that uses optical coherence tomography technology to capture detailed images of the cornea and anterior segment of the eye. It helps clinicians assess eye health and diagnose ocular conditions more accurately by providing high-resolution images of the eye structures.

HyperVue™ Software is an imaging system that uses Optical Coherence Tomography (OCT) technology to produce detailed images of cardiovascular structures. It helps clinicians by providing high-resolution images that assist in diagnosing and treating cardiovascular diseases.

The OPUSWAVE Dual Sensor Imaging System is a medical device that uses Optical Coherence Tomography to capture detailed images of cardiovascular structures. It helps clinicians by providing high-resolution imaging to assist in diagnosis and treatment of cardiovascular conditions.

The OPXION Optical Skin Viewer is a non-invasive optical coherence tomography system designed to provide real-time visualization of the external tissues of the human body. It generates two-dimensional, cross-sectional, three-dimensional, and en-face images of tissue microstructures, helping clinicians assess skin conditions with high-resolution imaging.

The SPECTRALIS HRA+OCT and variants by Heidelberg Engineering GmbH are non-contact ophthalmic imaging devices combining confocal laser-scanning ophthalmoscopy and spectral-domain optical coherence tomography (SD-OCT). They capture detailed cross-sectional and angiographic images of the eye, aiding clinicians in diagnosing and managing various ocular diseases such as macular degeneration, diabetic retinopathy, and glaucoma. These devices enhance visualization of ocular anatomy and vascular structures, improving clinical evaluation and patient care.

The Cornaris Intravascular Imaging System (P80-E and Mobile-E) with the LumenCross Imaging Catheter (F2) is an advanced intravascular imaging system designed to help clinicians visualize coronary arteries during transluminal interventional procedures. It uses optical coherence tomography technology to provide high-resolution images of the inside of blood vessels, aiding in diagnosis and treatment planning for patients with coronary artery conditions. The system enhances the ability to assess blood vessels safely and effectively, improving patient outcomes.

The Gentuity® HF-OCT Imaging System with Vis-Rx Prime® Micro-Imaging Catheter is a medical imaging device designed to provide high-resolution, real-time images of coronary arteries in patients undergoing transluminal interventional procedures. It uses near-infrared light delivered via a fiber-optic catheter to visualize coronary tissue, aiding clinicians in diagnosis and treatment planning.

Anterion is a non-contact ophthalmic imaging device that uses swept-source optical coherence tomography (SS-OCT) to visualize and measure the anterior segment of the eye, including corneal thickness, anterior chamber parameters, lens thickness, and axial length. It helps clinicians by providing detailed tomographic images and quantitative metrics critical for diagnosis and surgical planning, such as cataract surgery. The device includes multiple software applications for imaging and analysis and uses AI-powered processing for precise measurements, improving clinical decision-making and patient management.

The SPECTRALIS with Flex Module is an advanced eye imaging device designed for non-contact visualization of the posterior segment and vasculature of the retina and choroid in adults and pediatric patients, including those in supine (lying down) position. It helps ophthalmologists detect and monitor various eye conditions by providing high-quality images of eye structures, enabling improved diagnosis and management.

The Notal Vision Home OCT System is an AI-based home use device that enables patients with neovascular age-related macular degeneration (NV-AMD) to self-image their eyes at home using Optical Coherence Tomography (OCT). It captures detailed images of the retina, segments and quantifies hypo-reflective spaces associated with fluid build-up, and securely transmits data for physician review between scheduled clinic visits. This allows more frequent monitoring of eye disease progression without replacing standard clinical examinations.